Presentation for Sk community

1. AUTOMATED WORKPLACE FOR TISSUE
STUDIES

2. TEAM
Investor Investor
Artem Belov
Founder
Andrew Blokhin
Founder
Sergey Frolov
Scientific Advisor
Vyacheslav Molotkov Nikolai Zaichenko Cyril Mityagin
Investor

3. BASIC PATHOLOGY LAB
Oleg Molchanov Alexander Sazhin Vladimir Karjakin
Alexander Blokhin
We have professional
medical team of
pathologists with
extensive medical practice,
conducting 300 thousand
tissue studies per year.

4. PROBLEM
PATHOLOGY DIAGNOSTICS – basis for: diagnosis,
treatment assignment, evaluation of therapy effectiveness
subjective and not
reproducible
accumulation of
knowledge is limited to
their own experiences
data transfer is limited
or not available

5. EXAMPLE: HER2/Neu
Tissue IHC
0
1+
2+ ISH
-
+
Trastsuz
umab
3+
Trastsuz
umab
SCORE ERROR
0/1+ 12%
2+ 54%
3+ 18%
only in Russia ANNUAL LOSSES
from breast cancer diagnostic errors
are:
 $40 ml. of inefficient target drug
use
 7 ths. of patients will not have

6. SOLUTION
"DIGITAL TISSUE" is a reliable basis for support decision-
making medical system for the diagnosis, determine the
most effective treatment strategy
patent agent,
co-investor
AUTOMATED WORKPLACE for tissue studies based on
breakthrough machine vision technology

7. COMPETITION
Fold increase in the accuracy and objectivity of
diagnostic information at a lower cost solutions
Objectivity* ++ + +
Affordability $100 K $150 K $120 K

8. Consumer in global scale:
$1.2
$0.3
bln
bln
2015
2025
Consumer in
Russia:
> 3 ml oncology patients
> 100 pathology labs
> 60 ml oncology patients
> 2 k. pathology labs
FAST GROWING MARKET
The cancer profiling market: Digital pathology segment
In 2015 the global Digital Pathology market is $ 340 mln,
in 2025 segment will achieve $1.2 bln, CAGR– 11,4%.

9. EXIT STRATEGY
ACQUISITION WITHIN 5 YEARS
More than
10
comparable
deals
It invested $ 130 mln in
the Flatiron (May 2014)
Merge acquired for 1 bln
dollars. (August 2015)
Clarient acquired for $ 275
mln (October 2015)
Key M & A market players

10. Fast growing market
Unique technology
WHY SHOULD YOU INVEST?
High actuality of the problem
Artem Belov
+7-925-859-10-85
asb@chance2live.com